Hila Karah joined Pitango in 2022, and is a life Sciences investment professional with over 20 years of an extensive experience in Health Care investments and global business consulting to both private and public companies. Before joining Pitango, Hila was an independent business consultant to Health Tech and Health Services companies on strategy, operations, financing, regulatory and corporate governance and has had several management roles.
Prior to her consulting career, Hila was a Chief investment officer of Eurotrust Ltd., a family office, focused primarily on investments in life science and high tech companies. Before Eurotrust, Hila was a partner senior analyst at Perceptive Life Sciences Ltd., a leading New York-based Life Science hedge fund and as VP Research at Oracle Partners Ltd., a healthcare-focused hedge fund based in Connecticut. Hila also volunteer as an Oncology case manager and serves as a professional manager at Mifrasim, a NOP social venture.
Hila has a BA in molecular and cell biology from the University of California, Berkeley, and has studied at the UCBerkeley-UCSF Joint medical program. She currently serves as a director on the board of several companies including: Indaptus Therapeutics Ltd. (NASDAQ, INDP), Dario Health Corp. (NASDAQ; DRIO), Cyren Ltd. (NASDAQ, CYRN) and OncoHost Ltd.